Genetic Disorders: Neurofibromatosis and von Hippel-Lindau Disease
Both neurofibromatosis and von Hippel-Lindau Disease are genetic disorders that vary widely from patient to patient and even within the same family. Treatments of both generally involve taking care of the symptoms.
Neurofibromatosis
von Hippel-Lindau Disease
Research
The National Institute of Neurological Disorders and Strokes research teams have worked on identifying the NF and VHL genes and their makeup, sequences and patterns.
Other research is also aimed at improving methods of diagnosing the condition and identifying the factors that contribute to the variations of symptoms and severity.
WFUBMC Approach
The Medical Center offers a multidisciplinary approach to diagnosis, treatment and research on these disorders.
The Medical Center is a VHL Family Alliance designated Clinical Care Center. The goals of the alliance and these centers is to improve diagnosis and treatment of VHL, to provide coordination of care across medical specialties, to provide resource centers for patients and physicians who are new to VHL and to provide a ready channel for communicating advances to these centers of expertise..
The Medical Center is involved in neurofibromatosis research on methods to non-invasively treat the brain tumors and to preserve hearing using advanced stereotactic radiosurgery and other techniques.
back to top